Oluwatomisin Atolagbe to Humans
This is a "connection" page, showing publications Oluwatomisin Atolagbe has written about Humans.
Connection Strength
0.015
-
ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. J Exp Med. 2024 Apr 01; 221(4).
Score: 0.006
-
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7).
Score: 0.005
-
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention. Cancer Discov. 2021 03; 11(3):614-625.
Score: 0.005